INmune Bio signs master services agreement with Uniphar for named-patient access to Ebstrocel in Europe, MENA

INmune Bio announced a master services agreement with Uniphar for named-patient access to Ebstrocel in select European and MENA markets.

Detected & updated continuously · Source: Nebula

Story subjects

INmune Bio Inc.UnipharEbstrocel

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula